Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSL | P07711 | 10/20 | 0.54 |
| ▸ | CTSK | P43235 | 9/20 | 0.52 |
| ▸ | CTSB | P07858 | 5/20 | 0.51 |
| ▸ | CTSS | P25774 | 3/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6466343 | 1.00 | CTSL (0.54) | CTSLCTSKCTSBCTSS | |
| SCHEMBL7593794 | 0.91 | CTSL (0.46) | CTSLCTSBCTSS | |
| SCHEMBL6531737 | 0.90 | CTSL (0.43) | CTSLCTSKCTSBCTSS | |
| SCHEMBL6061622 | 0.87 | CTSL (0.54) | CTSLCTSKCTSBCTSS | |
| SCHEMBL6468739 | 0.87 | CTSL (0.54) | CTSLCTSKCTSBCTSS | |
| SCHEMBL6467377 | 0.83 | CTSL (0.54) | CTSLCTSKCTSBCTSS | |
| SCHEMBL6462122 | 0.78 | CTSL (0.59) | CTSLCTSKCTSBCTSS | |
| SCHEMBL7796791 | 0.78 | CTSL (0.67) | CTSLCTSKCTSBCTSS | |
| SCHEMBL7764593 | 0.77 | CTSL (0.65) | CTSLCTSKCTSBCTSS | |
| SCHEMBL6063247 | 0.76 | CTSL (0.68) | CTSLCTSKCTSBCTSS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1516877-A1 | Amine derivatives as protease inhibitors | AXYS PHARMACEUTICALS, INC. (US) | 2005-03-23 | — | — | EP | disclosed |
| US-20030232864-A1 | Novel Compounds and compositions as protease inhibitors | AXYS PHARMACEUTICALS, INC. (US) | 2003-12-18 | — | — | US | disclosed |
| US-6576630-B1 | Alkanoyl substituted benzooxazoles or naphthooxazoles | AXYS PHARMACEUTICALS, INC. | 2003-06-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030232864-A1 | Novel Compounds and compositions as protease inhibitors | SERPINB1, CTRL, CTSZ | CTSL 18/4885CTSK 32/4885CTSB 11/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.